Published: 2020-11-12 12:29 | Updated: 2020-11-12 12:44

27,4 MSEK from Cancerfonden to researchers at Labmed

Congratulations to the 6 researchers at Labmed who received funds from Cancerfonden 2021-2023.

Research projects

Mikael Björnstedt, Professor
Title: "Redoxaktiva selenföreningar i behandlingen av cancer - translationella och kliniska studier"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 3 000 000 SEK

 

Joakim Dillner, Professor
Title: "Translational studies on Human Papillomaviruses"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 6 750 000 SEK

 

Helen Kaipe, Researcher
Title: "Exploring tumor-infiltrating T cells and cancer-associated fibroblasts in the pancreatic tumor microenvironment - the role of chemokines for T cell infiltration"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 2 400 000 SEK

 

Anna Pasetto, Assistant professor
Title: "Establishing a platform for the treatment of Hepatocellular Carcinoma using genetically modified T cells"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 2 400 000 SEK

 

Matti Sällberg, Professor
Title: "Genetic vaccines and immune-based therapies to prevent cancer caused by chronic hepatitis B, C and D virus infections: Therapy development and models"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 3 750 000 SEK

Planning group

Jonas Fuxe, Professor
Title: "Swe-EMT; Svenska nätverket för translationella studier av cell plasticitet och cancer metastasering"
Funding granted: 2021-01-01 - 2022-12-31, total amount: 150 000 SEK

Additional funding

Joakim Dillner at the Division of Pathology has been approved additional funding for his research about cervical cancer. The project is one of the oldest grants at Cancerfonden and was approved in 1988.

 

Joakim Dillner, Professor
Title: "A preventive action for eradication of human papillomavirus (HPV) and elimination of cervical cancer from sweden"
Funding granted: 2021-01-01 - 2023-12-31, total amount: 9 000 000 SEK